WASHINGTON — Federal health regulators on Tuesday warned consumers against controversial “young blood” treatments — plasma infusions from young donors marketed for conditions such as Parkinson’s, Alzheimer’s, multiple sclerosis and post-traumatic stress disorder. “There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat or prevent these conditions and […]
